Issues in diisocyanate antibody testing

Critical Reviews in Toxicology

Volumn 37, Issue 7, 2007, Pages 567-585

  Ott, M Gerald ^a   Jolly, Athena T ^b   Burkert, Amy L ^c   Brown, William E ^c  

^a BASF CORPORATION   (United States)

^b Environmental and Occupational Medicine Consultant   (United States)

^c CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

Diisocyanate conjugate; ELISA methods; Isocyanate biomarker; Occupational asthma; Specific IgE; Specific IgG

Indexed keywords

ANTIBODY; CARRIER PROTEIN; CYANIC ACID DERIVATIVE; DIISOCYANATE; DIISOCYANATE ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ANTIGEN BINDING; ANTIGEN SPECIFICITY; CALIBRATION; CONJUGATION; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOASSAY; ISOELECTRIC FOCUSING; LABORATORY TEST; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING; QUALITATIVE ANALYSIS; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; STANDARDIZATION;

AIR POLLUTANTS, OCCUPATIONAL; ASTHMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; ISOCYANATES; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PREDICTIVE VALUE OF TESTS;

EID: 34547676277     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.1080/10408440701419553     Document Type: Review

References (102)

1. Anees, W., Gannon, P.F., Huggins, V., Pantin, C.F.A., and Burge, P.S. (2004). Effect of peak expiratory flow data quantity on diagnostic sensitivity and specificity in occupational asthma. Eur. Respir. J. 23:730-734.
2. Bascom, R., Kennedy, T.P., Levitz, D., and Zeiss, C.R. (1985). Specific bronchoalveolar lavage IgG antibody in hypersensitivity pneumonitis from diphenylmethane diisocyanate. Am. Rev. Respir. Dis. 131:463-465.
3. Baur, X. (1983). Immunological cross-reactivity between different albumin-bound isocyanates. J. Allergy Clin. Immunol. 71:197-205.
4. Baur, X., Dewair, M., and Fruhmann, G. (1984). Detection of immunologically sensitized isocyanate workers by RAST and intracutaneous skin test. J. Allergy Clin. Immunol. 73:610-618.
5. Baur, X., Marek, W., Ammon, J., Czuppon, A.B., Marczynski, B., Raulf-Heimsoth, M., Roemmelt, H., and Fruhmann, G. (1994). Respiratory and other hazards of isocyanates. Int. Arch. Occup. Environ. Health. 66:141-152.
6. Baur, X. (1995). Hypersensitivity pneumonitis (extrinsic allergic alveolitis) induced by isocyanates. J. Allergy Clin. Immunol. 95:1004-1010.
7. Baur, X., Chen, Z., Flagge, A., Posch, A., and Raulf-Heimsoth, M. (1996). EAST and CAP specificity for the evaluation of IgE and IgG antibodies to diisocyanate-HSA conjugates. Int. Arch. Allergy Immunol. 110:332-338.
8. Baur, X., Huber, H., Degens, P.O., Allmers, H., and Ammon, J. (1998). Relation between occupational asthma case history, bronchial methacholine challenge, and specific challenge test in patients with suspected occupational asthma. Am. J. Ind. Med. 33:114-122.
9. Bernstein, D.I., Korbee, L., Stauder, T., Bernstein, J.A., and Bernstein, I.L. (1993). The low prevalence of occupational asthma and antibody dependent sensitization to diphenylmethane diisocyanate (MDI) in a plant engineered for minimal exposure to diisocyanates. J. Allergy Clin. Immunol. 92:387-396.
10. Bernstein, D.I., and Jolly, A. (1999). Current diagnostic methods for diisocyanate induced occupational asthma. Am. J. Ind. Med. 36:459-468.
11. Bernstein, D.I., Cartier, A., Cote, J., Malo, J.L., Boulet, L.P., Wanner, M., Milot, J., L'Archeveque, J., Trudeau, C., and Lummus, Z. (2002). Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am. J. Respir. Crit. Care Med. 166:445-450.
12. Bernstein, D.I., Ott, M.G., Woolhiser, M., Lummus, Z.L., and Graham, C. (2006). Evaluation of antibody binding to diisocyanate-protein conjugates in a general population. Ann. Allergy Asthma Immunol. 97:357-364.
13. Bernstein, I.L. and Storms, W.W. (1995). Practice parameters for allergy diagnostic testing. Joint Task Force on Practice Parameters for the Diagnosis and Treatment of Asthma. The American Academy of Allergy, Asthma, and Immunology and the American College of Allergy, Asthma, and Immunology. Ann. Allergy Asthma Immunol. 75:543-625.
14. Brown, W.E. (1986). The chemistry and biochemistry of isocyanates: an overview. In: Current Topics in Pulmonary Pharmacology and Toxicology, M.A. Hollinger, ed., pp. 200-225. Elsevier, New York.
15. Brown, W.E., Gamaluddin, S., and Kennedy, A.L. (2002). Antibody testing: Analysis of the specificity of antibody detection in a non-diisocyanate-exposed population. In: Isocyanates: Sampling, Analysis, and Health Effects, ASTM STP 1408, J. Lesage, I.D. DeGraff, and R.S. Danchik, eds., pp. 80-93. American Society for Testing and Materials, West Conshohocken, PA.
16. Brown, W.E., and Burkert, A.L. (2002). Biomarkers of toluene diisocyanate exposure. Appl. Occup. Environ. Hyg. 17:840-845.
17. Butcher, B.T., O'Nel, C.E., Reed, M.A., and Salvaggio, J.E. (1980). Radioallergosorbent testing of toluene diisocyanate-reactive individuals using p-toly isocyanate antigen. J. Allergy Clin. Immunol. 66:213-216.
18. Butler, J.E., Ni, L., Brown, W.R., Joshi, K.S., Chang, J., Rosenberg, B., and Voss, E.W., Jr. (1993). The immunochemistry of sandwich ELISAs. VI. Greater than 90% of monoclonal and 75% of polyclonal anti-fluorescyl captured antibodies (Cabs) are denatured by passive adsorption. Mol. Immunol. 30:1165-1175.
19. Cartier, A., Grammer, L., Malo, J.L., Lagier, F., Ghezzo, H., Harris, K., and Patterson, R. (1989). Specific serum antibodies against isocyanates: association with occupational asthma. J. Allergy Clin. Immunol. 84:507-514.
20. Cullinan, P. (1998). Editorial: Occupational asthma, IgE and IgG. Clin Exp Allergy. 28:668-670.
21. Cullinan, P. (2004). Clinical aspects of occupational asthma. Panminerva Med. 46:111-120.
22. Cvitanovic, S., Zekan, L., and Marusic, M. (1989). Occurrence and specificity of IgE antibodies to isocyanates in occupationally exposed workers. Int. Arch. Occup. Environ. Health. 61:483-486.
23. Daftarian, H.S., Lushniak, B.D., Reh, C.M., and Lewis, D.M. (2002). Evaluation of self-reported skin problems among workers exposed to toluene diisocyanate (TDI) at a foam manufacturing facility. J. Occup. Environ. Med. 44:1197-1202.
24. Deschamps, F., Sow, M.L., Prevost, A., Henry, L., Lavaud, F., Bernard, J., and Kochman, S. (1998). Prevalence of respiratory symptoms and increased specific IgE levels in West-African workers exposed to isocyanates. J. Toxicol. Environ. Health. 54:335-342.
25. Dewair, M.A., and Baur, X. (1982). Studies on antigens useful for detection of IgE antibodies in isocyanate-sensitized workers. J. Clin. Chem. Clin. Biochem. 20:337-340.
26. Grammer, L.C., Eggum, P., Silverstein, M., Shaughnessy, M.A., Liotta, J.L., and Patterson, R. (1988). Prospective immunologic and clinical study of a population exposed to hexamethylene diisocyanate. J. Allergy Clin. Immunol. 82:627-633.
27. Grammer, L.C., Harris, K.E., Malo, J.L., Cartier, A., and Patterson, R. (1990). The use of an immunoassay index for antibodies against isocyanate human protein conjugates and application to human isocyanate disease. J. Allergy Clin. Immunol. 86:94-97.
28. Grammer, L., Shaughnessy, M., and Kenamore, B. (1998). Utility of antibody in identifying individuals who have or will develop anhydride-induced respiratory disease. Chest 114:1199-1202.
29. Grammer, L.C. (1999). Occupational allergic alveolitis. Ann. Allergy Asthma Immunol. 83:602-606.
30. Hagy, G.W., and Settipane, G.A. (1971). Prognosis of positive allergy skin tests in an asymptomatic population. J. Allergy Clin. Immunol. 48:200-211.
31. Hendrick, D.J. (2002). Diagnostic tests for occupational asthma. Am. J. Respir. Crit. Care Med. 166:436-437.
32. Jakobsson, K., Kronholm-Diab, K., Rylander, L., and Hagmar, L. (1997). Airway symptoms and lung function in pipelayers exposed to thermal degradation products from MDI-based polyurethanes. Occup Environ Med. 54:873-879.
33. Jin, R., and Karol, M.H. (1988). Intra- and intermolecular reactions of 4,4′-diisocyanatodiphenylmethane with human serum albumin. Chem. Res. Toxicol. 1:281-287.
34. Johannesson, G., Sennbro, C.J., Willix, P., Lindh, C.H., and Jonsson, B.A. (2004). Identification and characterisation of adducts between serum albumin and 4,4′-methylenediphenyl diisocyanate (MDI) in human plasma. Arch. Toxicol. 78:378-383.
35. Jones, M.G., Floyd, A., Nouri-Aria, K.T., Jacobson, M.R., Durham, S.R., Taylor, A.N., and Cullinan, P. (2006). Is occupational asthma to diisocyanates a non-IgE-mediated disease? J. Allergy Clin. Immunol. 117:663-669.
36. Karol, M.H. (1980). Study of guinea pig and human antibodies to toluene diisocyanate. Am. Rev. Respir. Dis. 122:965-970.
37. Karol, M.H. (1986). Respiratory effects of inhaled isocyanates. CRC Crit. Rev. Toxicol. 16:349-379.
38. Karol, M.H., and Alarie, Y. (1980). Antigens which detect IgE antibodies in workers sensitive to toluene diisocyanate. Clin. Allergy 10:101-109.
39. Karol, M.H., Tollerud, D.J., Campbell, T.P., Fabbri, L., Maestrelli, P., Saetta, M., and Mapp, C.E. (1994). Predictive value of airways hyperresponsiveness and circulating IgE for identifying types of responses to toluene diisocyanate inhalation challenge. Am. J. Respir. Crit. Care Med. 149:611-615.
40. Karol, M.H., Kramarik, J.A., and Ferguson, J. (1995). Methods to assess RAST results in patients exposed to chemical allergens. Allergy 50:48-54.
41. Kennedy, A. L. (1990). The in vivo reactivity of inhaled isocyanates: comparative analysis of cellular and macromolecular targets. PhD thesis, Carnegie Mellon University, Pittsburgh, PA.
42. Kennedy, A.L., and Brown, W.E. (1992). Isocyanates and lung disease: Experimental approaches to molecular mechanisms. In: Occupational Lung Disease, W.S. Beckett, and R. Bascom, eds., pp. 301-330. Hanley & Belfus, Philadelphia.
43. Keskinen, H., Tupasela, O., Tiikkainen, U., and Nordman, H. (1988). Experiences of specific IgE in asthma due to diisocyanates. Clin. Allergy. 18:597-604.
44. Kim, H., Kim, Y.-D., and Choi, J. (1997). Seroimmunological characteristics of Korean workers exposed to toluene diisocyanate. Environ. Res. 75:1-6.
45. Lange, R.W., Lantz, R.C., Stolz, D.B., Watkins, S.C., Sundareshan, P., Lemus, R., and Karol, M.H. (1999). Toluene diisocyanate colocalizes with tubulin on cilia of differentiated human airway epithelial cells. Toxicol. Sci. 50:64-71.
46. Lantz, R.C., Lemus, R., Lange, R.W., and Karol, M.H. (2001). Rapid reduction in intracellular glutathione in human bronchial epithelial cells exposed to occupational levels of toluene diisocyanate. Toxcol. Sci. 60:348-355.
47. Levine, S.P., Redinger, C.F., and Robert, W.P. (2001). Community exposure assessment and intervention effectiveness at Trinity American Corporation, Glenola, North Carolina. AIHA J. 62:649-657.
48. Lind, P., Dalene, M., Lindstrom, V., Grubb, A., and Skarping, G. (1997). Albumin adducts in plasma from workers exposed to toluene diisocyanate. Analyst 122:151-154.
49. Liss, G.M., Bernstein, D.I., Moller, D.R., Gallagher, J.S., Stephenson, R.L., and Bernstein, I.L., (1988). Pulmonary and immunologic evaluation of foundryworkers exposed to methylene diphenyldiisocyanate (MDI). J. Allergy Clin. Immunol. 82:55-61.
50. Lushniak, B.D., Reh, C.M., Bernstein, D.I., and Gallagher, J.S. (1998). Indirect assessment of 4,4′-diphenylmethane diisocyanate (MDI) exposure by evaluation of specific humoral immune responses to MDI conjugated to human serum albumin. Am. J. Ind. Med. 33:471-477.
51. Lynn, F., Reed, G.F., and Meade, B.D. (1996). Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens. Clin. Diagn. Lab. Immunol. 3:689-700.
52. Malo, J.L., Ouimet, G., Cartier, A., Levitz, D., and Zeiss, C.R. (1983). Combined alveolitis and asthma due to hexamethylene diisocyanate (HDI), with demonstration of crossed respiratory and immunologic reactivities to diphenylmethane diisocyanate (MDI). J. Allergy Clin. Immunol. 72:413-419.
53. Malo, J.L., Ghezzo, H., L'Archeveque, J., Lagier, F., Perrin, B., and Cartier, A. (1991). Is the clinical history a satisfactory means of diagnosing occupational asthma? Am. Rev. Respir. Dis. 143:528-532.
54. Malo, J.L., L'Archevêque, J., Lummus, Z., and Bernstein, D. (2006). Changes in specific IgE and IgG and monocyte chemoattractant protein-1 in workers with occupational asthma caused by diisocyanates and removed from exposure. J. Allergy Clin. Immunol. 118:530-533.
55. Mapp, C.E., Butcher, B.T., and Fabbri, L.M. (1999). Polyisocyanates and their prepolymers. In: Asthma in the Workplace, 2nd ed., I.L. Bernstein, M. Chan-Yeung, J.L. Malo, and D.I. Bernstein, eds., pp. 457-478. Marcel Dekker, New York.
56. Martin, J.N., Amad, Z., Cossen, C., Lam, P.K., Kedes, D.H., Page-Shafer, K.A., Osmond, D.H., and Forghani, B. (2000). Use of epidemiologically well-defined subjects and existing immunofluorescence assays to calibrate a new enzyme immunoassay for human herpesvirus 8 antibodies. J. Clin. Microbiol. 38:696-701.
57. Mazur, G., and Pethran, A. (1993). Detection of specific IgE in isocyanate and phthalic anhydride exposed workers: Comparison of RAST RIA, Immuno CAP System FEIA, and Magic Lite SQ. Allergy 48:627-630.
58. McPherson, R.A., and Massey, H.D. Laboratory evaluation of immunoglobulin function and humoral immunity. In: Henry's Clinical Diagnosis and Management by Laboratory Methods, 21st ed., chap. 45. WB Saunders, Philadelphia, PA.
59. Moscato, G., Malo, J.L., and Bernstein, D. (2003). Diagnosing occupational asthma: How, how much, how far? Eur. Respir. J. 21:879-885.
60. Nielsen, S.S. (2002). Variance components of an enzyme-linked immunosorbent assay for detection of IgG antibodies in milk samples to Mycobacterium avium subspecies paratuberculosis in dairy cattle. J. Vet. Med. B Infect. Dis. Vet. Public Health. 49:384-387.
61. Nosko, M., Altunkova, I., Baltadjieva, D., Liapin, M., Bocheva, S., and Tanev, M. (1998). Immune mechanisms of the occupational sensitization with methylene diphenyl diisocyanate (MDI). Central Eur. J. Public Health 6:199-201.
62. Nuorteva, P., Assmuth, T., Haahtela, T., Ahti, J., Kurvonen, E., Nieminen, T., Saarainen, T., Seppala, K., Veide, P., and Viholainen, S. (1987). The prevalence of asthma among inhabitants in the vicinity of a polyurethane factory in Finland. Environ Res. 43:308-316.
63. Orloff, K.G., Batts-Osborne, D., Kilgus, T., Metcalf, S., and Cooper, M. (1998). Antibodies to toluene diisocyanate in an environmentally exposed population. Environ. Health Perspect. 106:665-666.
64. Park, H.S., and Nahm, D.H. (1996). Isocyanate-induced occupational asthma: challenge and immunologic studies. J. Korean Med. Sci. 4:314-318.
65. Park, H.S., and Nahm, D.H. (1997). Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure. Clin. Exp. Allergy 27:1145-1150.
66. Park, H.S., Kim, H.Y., Nahm, D.H., Son, J.J. and Kim, Y.Y. (1999). Specific IgG, but not specific IgE, antibodies to toluene diisocyanatehuman serum albumin conjugate are associated with toluene diisocyanate bronchoprovocation test results. J. Allergy Clin. Immunol. 104:847-851.
67. Park, H.S., Lee, S.K., Lee, S.K., Lee, Y.M., Kim, S.S., and Nahm, D.H. (2002). Longitudinal study of specific antibodies to toluene diisocyanate (TDI)-human serum albumin (HSA) conjugate in patients with TDI-induced asthma. Korean J. Int. Med. 17:249-251.
68. Patterson, R., Zeiss, C.R., and Pruzansky, J.J. (1982). Immunology and immunopathology of trimellitic anhydride pulmonary reactions. J. Allergy Clin. Immunol. 70:19-23.
69. Patterson, R., Beltrani, V.S., Singal, M., Gorman, R.W., Zeiss, C.R., and Harris, KE. (1985). Creating an indoor environmental problem from a nonproblem: A need for cautious evaluation of antibodies against hapten-protein complexes. N. Engl. Reg. Allergy Proc. 6:135-139.
70. Patterson, R., Hargreave, F.E., Grammer, L.C., Harris, K.E., and Dolovich, J. (1987). Toluene diisocyanate respiratory reactions. Int. Arch. Allergy Appl. Immunol. 84:93-100.
71. Pemberton, D. (2001). MDI and TDI: Vapour pressures and saturated vapour concentrations. Gilbert International Limited, Manchester, UK, Report Number 2001/C.
72. Peterman, J.H., Tarcha, P.J., Chu, V.P., and Butler, J.E. (1988). The immunochemistry of sandwich-ELISAs. IV. The antigen capture capacity of antibody covalently attached to bromoacetyl surface-functionalized polystyrene. J. Immunol. Methods. 111:271-275.
73. Petsonk, E.L., Wang, M.L., Lewis, D.M., Siegel, P., and Husberg, B.J. (2000). Asthma-like symptoms in wood product plant workers exposed to methylene diphenyl diisocyanate. Chest 118:1183-1193.
74. Pezzini, A., Riviera, A., Paggiaro, P., Spiazzi, A., Gerosa, F., Filieri, M., Toma, G., and Tridente, G. (1984). Specific IgE antibodies in twenty-eight workers with diisocyanate-induced bronchial asthma. Clin. Allergy 14:453-461.
75. Prussin, C., and Metcalfe, D.D. (2006). 5. IgE, mast cells, basophils, and eosinophils. J. Allergy Clin. Immunol. 117:S450-456.
76. Raulf-Heimsoth, M., and Baur, X. (1998). Pathomechanisms and pathophysiology of isocyanate-induced disease - Summary of present knowledge. Am. J. Ind. Med. 34:137-143.
77. Redlich, C.A., and Karol, M.H. (2002). Diisocyanate asthma: Clinical aspects and immunopathogenesis. Int. Immunopharmacol. 2:213-24.
78. Redlich, C.A., Stowe, M.H., Wisnewski, A.V., Eisen, E.A., Karol, M.H., Lemus, R., Holm, C.T., Chung, J.S., Sparer, J., Liu, Y., Woskie, S.R., Appiah-Pippim, J., Gore, R., and Cullen, M.R. (2001). Subclinical immunologic and physiologic responses in hexamethylene diisocyanate-exposed auto body shop workers. Am. J. Ind. Med. 39:587-597.
79. Rosenberg, C., and Savolainen, H. (1986). Determination of occupational exposure to toluene diisocyanate by biological monitoring. J. Chromatogr. 367:385-392.
80. Sabbioni, G., Hartley, R., and Schneider, S. (2001). Synthesis of adducts with amino acids as potential dosimeters for the biomonitoring of humans exposed to toluenediisocyanate. Chem. Res. Toxicol. 14:1573-1583.
81. Selden, A.I., Belin, L., and Waas, U. (1989). Isocyanate exposure and hypersensitivity pneumonitis - Report of a probable case and prevalence of specific immunoglobulin G antibodies among exposed individuals. Scand. J. Work Environ. Health 15:234-237.
82. Sennbro, C.J., Littorin, M., Tinnerberg, H., and Jönsson, B.A.G. (2005). Upper reference limits for biomarkers of exposure to aromatic diisocyanates. Int. Arch. Environ. Health 78:541-546.
83. Skarping, G., Brorson, T., and Sangö, C. (1991). Biological monitoring of isocyanates and related amines. III. Test chamber exposure of humans to toluene diisocyanate. Int. Arch. Occup. Environ. Health 63:83-88.
84. Skarping, G., Dalene, M., Svensson, B.G., Littorin, M., Åkesson, B., and Welinder, H. (1996). Biomarkers of exposure, antibodies, and respiratory symptoms in workers heating polyurethane glue. Occup. Environ. Med. 53:180-187.
85. Son, M., Lee, M., Kim, Y.T., Youn, J.K., and Park, H.S. (1998). Heterogeneity of IgE response to TDI-HSA conjugates by ELISA in toluene diisocyanate (TDI)-induced occupational asthma patients. J. Korean Med. Sci. 13:147-152.
86. Spiazzi, A., Boccagni, P., Germano, P., and Pezzini, A. (1991). RAST-detection of specific IgE in diphenylmethane diisocyanate exposed workers. Allergy 46:166-172.
87. Tarlo, S.M., Banks, D., Liss, G., and Broder, I. (1997). Outcome determinants for isocyanate induced occupational asthma among compensation claimants. Occup. Environ. Med. 54:756-761.
88. Tarlo, S.M., and Malo, J.L. (2006). An ATS/ERS report: 100 Key questions and needs in occupational asthma. Eur. Respir. J. 27:607-614.
89. Taylor, A.J., Venables, K.M., Durham, S.R., Graneek, B.J., and Topping, M.D. (1987). Acid anhydrides and asthma. Int. Arch. Allergy Appl. Immunol. 82:435-439.
90. Tee, R.D., Cullinan, P., Welch, J., Burge, P.S., and Newman-Taylor, A.J. (1998). Specific IgE to isocyanates: A useful diagnostic role in occupational asthma. J. Allergy Clin. Immunol. 101:709-715.
91. Tse, K.S., Johnson, A., Chan, H., and Chan-Yeung, M. (1985). A study of serum antibody activity in workers with occupational exposure to diphenylmethane diisocyanate. Allergy 40:314-320.
92. Van Regenmortel, M.H. (2001). Antigenicity and immunogenicity of synthetic peptides. Biologicals 29:209-213.
93. Vandenplas, O., Cartier, A., Lesage, J., Cloutier, Y., Perreault, G., Grammer, L.C., Shaughnessy, M.A., and Malo, J.L. (1993). Prepolymers of hexamethylene diisocyanate as a cause of occupational asthma. J. Allergy Clin. Immunol. 91:850-861.
94. Vandenplas, O., Malo, J.L., Dugas, M., Cartier, A., Desjardins, A., Levesque, J., Shaughnessy, M.A., and Grammer, L.C. (1993). Hypersensitivity pneumonitis-like reaction among workers exposed to diphyenylmethane diisocyanate (MDI). Am. Rev. Respir. Dis. 147:338-346.
95. Walker, C.L., Grammer, L.C., Shaughnessy, M.A., Duffy, M., Stoltzfus, V.D., and Patterson, R. (1989). Diphyenylmethane diisocyanate hypersensitivity pneumonitis: A serologic evaluation. J. Occup. Med. 31:315-319.
96. Wass, U., and Belin, L. (1989). Immunologic specificity of isocyanate-induced IgE antibodies in serum from 10 sensitized workers. J. Allergy Clin. Immunol. 83:126-35.
97. Welinder, H., Nielsen, J., Bensryd, I., and Skerfving, S. (1988). IgG antibodies against polyisocyanates in car painters. Clin. Allergy. 18:85-93.
98. Wisnewski, A.V., Lemus, R., Karol, H.M., and Redlich, C.A. (1999). Isocyanate-conjugated human lung epithelial cell proteins: a link between exposure and asthma? J. Allergy Clin. Immunol. 104:341-347.
99. Wisnewski, A.V., Srivastava, R., Herick, C., Xu, L., Lemus, R., Cain, H., Magoski, N.M., Karol, M.H., Bottomly, K., and Redlich, C.A. (2000). Identification of human lung and skin proteins conjugated with hexamethylene diisocyanate in vitro and in vivo. Am. J. Respir. Crit. Care Med. 162:2330-2336.
100. Wisnewski, A.V., Stowe, M.H., Cartier, A., Liu, Q., Liu, J., Chen, L., and Redlich, C.A. (2004). Isocyanate vapor-induced antigenicity of human albumin. J. Allergy Clin. Immunol. 113:1178-1184.
101. Ye, Y.M., Kim, C.W., Kim, H.R., Kim, H.M., Suh, C.H., Nahm, D.H., Park, H.S., Redlich, C.A., and Wisnewski, A.V. (2006). Biophysical determinants of toleuene diisocyanate antigenicity associated with exposure and asthma. J. Allergy Clin. Immunol 118:885-891.
102. Zammit-Tabona, M., Sherkin, M., Kijek, K., Chan, H., and Chan-Yeung, M. (1983). Asthma caused by diphenylmethane diisocyanate in foundry workers: Clinical, bronchial provocation, and immunologic studies. Am. Rev. Respir. Dis. 128:226-230.